New trial data in melanoma and early findings in head and neck cancer are advancing individualized vaccines, while questions remain about durability, biomarkers, and delivery.

Scientists are reporting troubling signs that some recent mutations of the virus that causes COVID-19 may modestly curb the effectiveness of two current vaccines, although they stress that the shots ...

New details have emerged about an initiative that starts in December to fast-track the vaccines, similar to the successful ...

A new study provides early evidence that a Covid-19 vaccine might be effective against two new coronavirus strains first identified in South Africa and the UK, despite a concerning mutation. The two ...

A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University ...